Cargando…
Costs incurred by people receiving tuberculosis treatment in low-income and middle-income countries: a meta-regression analysis
BACKGROUND: People accessing and completing treatment for tuberculosis can face large economic costs, even when treatment is provided free of charge. The WHO End TB Strategy targets the elimination of catastrophic costs among tuberculosis-affected households. While low-income and middle-income count...
Autores principales: | Portnoy, Allison, Yamanaka, Takuya, Nguhiu, Peter, Nishikiori, Nobuyuki, Garcia Baena, Ineés, Floyd, Katherine, Menzies, Nicolas A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10522775/ https://www.ncbi.nlm.nih.gov/pubmed/37734806 http://dx.doi.org/10.1016/S2214-109X(23)00369-8 |
Ejemplares similares
-
The cost and cost-effectiveness of novel tuberculosis vaccines in low- and middle-income countries: A modeling study
por: Portnoy, Allison, et al.
Publicado: (2023) -
The potential impact of novel tuberculosis vaccines on health equity and financial protection in low-income and middle-income countries
por: Portnoy, Allison, et al.
Publicado: (2023) -
What We Do Not Know About the Costs of Immunization Programs in Low- and Middle-Income Countries
por: Portnoy, Allison, et al.
Publicado: (2021) -
The impact of alternative delivery strategies for novel tuberculosis vaccines in low-income and middle-income countries: a modelling study
por: Clark, Rebecca A, et al.
Publicado: (2023) -
National tuberculosis spending efficiency and its associated factors in 121 low-income and middle-income countries, 2010–19: a data envelopment and stochastic frontier analysis
por: Abou Jaoude, Gerard Joseph, et al.
Publicado: (2022)